Axsome Product Revenue Climbs 52% as Quarterly Loss Narrows
Axsome reported $259.7 million in third-quarter net product revenue and a $12.9 million net loss, while advancing a smoking-cessation trial.
Makkler Newsroom · Nov 2, 03:21 PM · 1 min read
Axsome Therapeutics, Inc. AXSM
NASDAQHealth TechnologyUnited States
$141.69-2.68 (-1.86%)
Market closed· · USD · Data may be delayed
- Day's range
- 136.63145.29
- 52-week range
- 123.00260.19
Financial health
– / 5
Analyst view · 23 firms
Buy22 buy · 1 hold · 0 sell
Avg. target $264.62 (+86.8%)
Prices may be delayed and are for informational purposes only - not investment advice.